Serge Palaric’s Post

Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare

Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog

Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog

developer.nvidia.com

To view or add a comment, sign in

Explore topics